Limits...
Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers.

Strong AL, Ohlstein JF, Biagas BA, Rhodes LV, Pei DT, Tucker HA, Llamas C, Bowles AC, Dutreil MF, Zhang S, Gimble JM, Burow ME, Bunnell BA - Breast Cancer Res. (2015)

Bottom Line: BCCs co-cultured with obASCs demonstrated enhanced expression of epithelial-to-mesenchymal transition (EMT) and metastasis genes (SERPINE1, MMP-2, and IL-6), while BCCs co-cultured with leptin shRNA obASCs did not display similar levels of gene induction.Knockdown of leptin significantly reduced tumor volume and decreased the number of metastatic lesions to the lung and liver.These results correlated with reduced expression of both SERPINE1 and MMP-2 in tumors formed with MCF7 cells mixed with leptin shRNA obASCs, when compared to tumors formed with MCF7 cells mixed with control shRNA obASCs.

View Article: PubMed Central - PubMed

Affiliation: Center for Stem Cell Research and Regenerative Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-99, New Orleans, LA, 70112, USA. alin1@tulane.edu.

ABSTRACT

Introduction: The steady increase in the incidence of obesity among adults has been paralleled with higher levels of obesity-associated breast cancer. While recent studies have suggested that adipose stromal/stem cells (ASCs) isolated from obese women enhance tumorigenicity, the mechanism(s) by which this occurs remains undefined. Evidence suggests that increased adiposity results in increased leptin secretion from adipose tissue, which has been shown to increased cancer cell proliferation. Previously, our group demonstrated that ASCs isolated from obese women (obASCs) also express higher levels of leptin relative to ASCs isolated from lean women (lnASCs) and that this obASC-derived leptin may account for enhanced breast cancer cell growth. The current study investigates the impact of inhibiting leptin expression in lnASCs and obASCs on breast cancer cell (BCC) growth and progression.

Methods: Estrogen receptor positive (ER+) BCCs were co-cultured with leptin shRNA lnASCs or leptin shRNA obASCs and changes in the proliferation, migration, invasion, and gene expression of BCCs were investigated. To assess the direct impact of leptin inhibition in obASCs on BCC proliferation, MCF7 cells were injected alone or mixed with control shRNA obASCs or leptin shRNA obASCs into SCID/beige mice.

Results: ER+ BCCs were responsive to obASCs during direct co-culture, whereas lnASCs were unable to increase ER(+) BCC growth. shRNA silencing of leptin in obASCs negated the enhanced proliferative effects of obASC on BCCs following direct co-culture. BCCs co-cultured with obASCs demonstrated enhanced expression of epithelial-to-mesenchymal transition (EMT) and metastasis genes (SERPINE1, MMP-2, and IL-6), while BCCs co-cultured with leptin shRNA obASCs did not display similar levels of gene induction. Knockdown of leptin significantly reduced tumor volume and decreased the number of metastatic lesions to the lung and liver. These results correlated with reduced expression of both SERPINE1 and MMP-2 in tumors formed with MCF7 cells mixed with leptin shRNA obASCs, when compared to tumors formed with MCF7 cells mixed with control shRNA obASCs.

Conclusion: This study provides mechanistic insight as to how obesity enhances the proliferation and metastasis of breast cancer cells; specifically, obASC-derived leptin contributes to the aggressiveness of breast cancer in obese women.

No MeSH data available.


Related in: MedlinePlus

Leptin inhibition in adipose stromal/stem cells isolated from obese women (obASCs) reduces tumor volume. MCF7 cells were prepared alone or co-injected with control short hairpin shRNA (control shRNA) obASCs or leptin shRNA obASCs (1:1 ratio) into the mammary fat pad of SCID/beige mice (n = 5 mice/group). a Tumor volume was assessed every 3–4 days. b Representative tumors from each mouse (n = 5/group). Scale bar represents 1 cm. c Tumor weight on day 36. d Representative images of H&E, green fluorescent protein (GFP) staining, and dsRed staining of tumor sections visualized at × 10 and × 40 magnification (inset). Scale bar represents 50 μm. Bar represents ± standard error of the mean. *P <0.001 relative to MCF7 xenografts; ΦP <0.001 for comparison between MCF7 plus control shRNA obASC xenografts and MCF7 plus leptin shRNA obASC xenografts
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4541745&req=5

Fig5: Leptin inhibition in adipose stromal/stem cells isolated from obese women (obASCs) reduces tumor volume. MCF7 cells were prepared alone or co-injected with control short hairpin shRNA (control shRNA) obASCs or leptin shRNA obASCs (1:1 ratio) into the mammary fat pad of SCID/beige mice (n = 5 mice/group). a Tumor volume was assessed every 3–4 days. b Representative tumors from each mouse (n = 5/group). Scale bar represents 1 cm. c Tumor weight on day 36. d Representative images of H&E, green fluorescent protein (GFP) staining, and dsRed staining of tumor sections visualized at × 10 and × 40 magnification (inset). Scale bar represents 50 μm. Bar represents ± standard error of the mean. *P <0.001 relative to MCF7 xenografts; ΦP <0.001 for comparison between MCF7 plus control shRNA obASC xenografts and MCF7 plus leptin shRNA obASC xenografts

Mentions: In order to investigate the effects of leptin silencing on tumorigenesis, MCF7 cells were implanted alone or mixed with control shRNA obASCs or leptin shRNA obASCs into the mammary fat pad of SCID/beige mice. After 36 days, tumors formed with MCF7 cells mixed with leptin shRNA obASCs were significantly smaller (1115.1 ± 36.7 mm3 and 1.22 ± 0.03 g) compared to tumors formed with MCF7 cells mixed with control shRNA obASCs (2141.5 ± 29.5 mm3 and 1.92 ± 0.03 g) (P <0.001; Fig. 5a-c). Histological assessment of the tumors confirmed that the bulk of the tumor was composed of GFP expressing MCF7 cells (Fig. 5d). Furthermore, immunohistochemical analysis confirmed the presence of dsRed expressing ASCs in tumors formed with control shRNA obASCs mixed with MCF7 cells. In contrast, dsRed expression was not visible in tumors formed with MCF7 alone or mixed with leptin shRNA obASCs (Fig. 5d).Fig. 5


Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers.

Strong AL, Ohlstein JF, Biagas BA, Rhodes LV, Pei DT, Tucker HA, Llamas C, Bowles AC, Dutreil MF, Zhang S, Gimble JM, Burow ME, Bunnell BA - Breast Cancer Res. (2015)

Leptin inhibition in adipose stromal/stem cells isolated from obese women (obASCs) reduces tumor volume. MCF7 cells were prepared alone or co-injected with control short hairpin shRNA (control shRNA) obASCs or leptin shRNA obASCs (1:1 ratio) into the mammary fat pad of SCID/beige mice (n = 5 mice/group). a Tumor volume was assessed every 3–4 days. b Representative tumors from each mouse (n = 5/group). Scale bar represents 1 cm. c Tumor weight on day 36. d Representative images of H&E, green fluorescent protein (GFP) staining, and dsRed staining of tumor sections visualized at × 10 and × 40 magnification (inset). Scale bar represents 50 μm. Bar represents ± standard error of the mean. *P <0.001 relative to MCF7 xenografts; ΦP <0.001 for comparison between MCF7 plus control shRNA obASC xenografts and MCF7 plus leptin shRNA obASC xenografts
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4541745&req=5

Fig5: Leptin inhibition in adipose stromal/stem cells isolated from obese women (obASCs) reduces tumor volume. MCF7 cells were prepared alone or co-injected with control short hairpin shRNA (control shRNA) obASCs or leptin shRNA obASCs (1:1 ratio) into the mammary fat pad of SCID/beige mice (n = 5 mice/group). a Tumor volume was assessed every 3–4 days. b Representative tumors from each mouse (n = 5/group). Scale bar represents 1 cm. c Tumor weight on day 36. d Representative images of H&E, green fluorescent protein (GFP) staining, and dsRed staining of tumor sections visualized at × 10 and × 40 magnification (inset). Scale bar represents 50 μm. Bar represents ± standard error of the mean. *P <0.001 relative to MCF7 xenografts; ΦP <0.001 for comparison between MCF7 plus control shRNA obASC xenografts and MCF7 plus leptin shRNA obASC xenografts
Mentions: In order to investigate the effects of leptin silencing on tumorigenesis, MCF7 cells were implanted alone or mixed with control shRNA obASCs or leptin shRNA obASCs into the mammary fat pad of SCID/beige mice. After 36 days, tumors formed with MCF7 cells mixed with leptin shRNA obASCs were significantly smaller (1115.1 ± 36.7 mm3 and 1.22 ± 0.03 g) compared to tumors formed with MCF7 cells mixed with control shRNA obASCs (2141.5 ± 29.5 mm3 and 1.92 ± 0.03 g) (P <0.001; Fig. 5a-c). Histological assessment of the tumors confirmed that the bulk of the tumor was composed of GFP expressing MCF7 cells (Fig. 5d). Furthermore, immunohistochemical analysis confirmed the presence of dsRed expressing ASCs in tumors formed with control shRNA obASCs mixed with MCF7 cells. In contrast, dsRed expression was not visible in tumors formed with MCF7 alone or mixed with leptin shRNA obASCs (Fig. 5d).Fig. 5

Bottom Line: BCCs co-cultured with obASCs demonstrated enhanced expression of epithelial-to-mesenchymal transition (EMT) and metastasis genes (SERPINE1, MMP-2, and IL-6), while BCCs co-cultured with leptin shRNA obASCs did not display similar levels of gene induction.Knockdown of leptin significantly reduced tumor volume and decreased the number of metastatic lesions to the lung and liver.These results correlated with reduced expression of both SERPINE1 and MMP-2 in tumors formed with MCF7 cells mixed with leptin shRNA obASCs, when compared to tumors formed with MCF7 cells mixed with control shRNA obASCs.

View Article: PubMed Central - PubMed

Affiliation: Center for Stem Cell Research and Regenerative Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, SL-99, New Orleans, LA, 70112, USA. alin1@tulane.edu.

ABSTRACT

Introduction: The steady increase in the incidence of obesity among adults has been paralleled with higher levels of obesity-associated breast cancer. While recent studies have suggested that adipose stromal/stem cells (ASCs) isolated from obese women enhance tumorigenicity, the mechanism(s) by which this occurs remains undefined. Evidence suggests that increased adiposity results in increased leptin secretion from adipose tissue, which has been shown to increased cancer cell proliferation. Previously, our group demonstrated that ASCs isolated from obese women (obASCs) also express higher levels of leptin relative to ASCs isolated from lean women (lnASCs) and that this obASC-derived leptin may account for enhanced breast cancer cell growth. The current study investigates the impact of inhibiting leptin expression in lnASCs and obASCs on breast cancer cell (BCC) growth and progression.

Methods: Estrogen receptor positive (ER+) BCCs were co-cultured with leptin shRNA lnASCs or leptin shRNA obASCs and changes in the proliferation, migration, invasion, and gene expression of BCCs were investigated. To assess the direct impact of leptin inhibition in obASCs on BCC proliferation, MCF7 cells were injected alone or mixed with control shRNA obASCs or leptin shRNA obASCs into SCID/beige mice.

Results: ER+ BCCs were responsive to obASCs during direct co-culture, whereas lnASCs were unable to increase ER(+) BCC growth. shRNA silencing of leptin in obASCs negated the enhanced proliferative effects of obASC on BCCs following direct co-culture. BCCs co-cultured with obASCs demonstrated enhanced expression of epithelial-to-mesenchymal transition (EMT) and metastasis genes (SERPINE1, MMP-2, and IL-6), while BCCs co-cultured with leptin shRNA obASCs did not display similar levels of gene induction. Knockdown of leptin significantly reduced tumor volume and decreased the number of metastatic lesions to the lung and liver. These results correlated with reduced expression of both SERPINE1 and MMP-2 in tumors formed with MCF7 cells mixed with leptin shRNA obASCs, when compared to tumors formed with MCF7 cells mixed with control shRNA obASCs.

Conclusion: This study provides mechanistic insight as to how obesity enhances the proliferation and metastasis of breast cancer cells; specifically, obASC-derived leptin contributes to the aggressiveness of breast cancer in obese women.

No MeSH data available.


Related in: MedlinePlus